Zymeworks
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Zymeworks
May 26, 2024, 10:23 |
Insight
Raffaele Colombo: We always learn a lot from the publications of “unsuccessful” trials
Raffaele Colombo shared on X/Twitter: "We always learn a lot from the publications of 'unsuccessful' trials.…
May 19, 2024, 13:37 |
Insight
Charles Chen: Check out our recent publication about PK/PD framework for ADC!
Charles Chen, Senior Director of Clinical Pharmacology and Translational Sciences at Zymeworks, shared a post…
May 13, 2024, 14:12 |
Blog
Raffaele Colombo: Personal selection of 30 new ADCs that will be presented at ASCO24
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: "Personal selection of…
Apr 8, 2024, 15:15 |
Blog
Raffaele Colombo: AACR Annual Meeting 2024 has started!
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on LinkedIn: "AACR Annual Meeting…
Nov 4, 2023, 00:58 |
Drugs
Raffaele Colombo: Here the breakdown of the Monomethyl auristatin E Antibody Drug Conjugates
Raffaele Colombo, Principal Scientist at Zymeworks, shared on X/Twitter: 106 auristatin Antibody Drug Conjugates (ADCs)…
All:
5
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube